Cite
HARVARD Citation
Zhou, X. et al. (n.d.). 367 Effects of alisertib (MLN8237), an investigational Aurora A kinase inhibitor (AAKi), on the QTc interval in patients (pts) with advanced malignancies. European journal of cancer. pp. S76-S77. [Online].